Tag Archives: glucagon/GLP-1 receptor

Boehringer Ingelheim Advances Dual Agonist Survodutide to Phase III Trials, Demonstrating Significant Weight Loss in Phase II Study

Posted on 18, August 2023 by EuropaWire PR Editor

(IN BRIEF) Pharmaceutical company Boehringer Ingelheim has declared its intention to move forward with survodutide, a dual agonist targeting the glucagon/GLP-1 receptors, into three Phase III clinical trials for individuals suffering from overweight or obesity. This decision stems from promising … Read the full press release →

Posted in Business, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science

Tagged Boehringer Ingelheim, Carinne Brouillon, Dual Agonist, glucagon/GLP-1 receptor, Obesity, overweight, Phase II Study, Phase III Trials, Survodutide, Weight loss